SKI Market

Indian Indices

Nifty

25,597.65 -165.70
(-0.64%)

Sensex

83,459.15 -519.34
( -0.62%)

Bank Nifty

57,827.05 -274.40
( -0.47%)

Nifty IT

35,274.55 -378.50
( -1.06%)

Global Indices

Nasdaq

47,102.64 -255.05
(-0.54%)

Dow Jones

6,792.56 -80.41
(-1.17%)

Hang Seng

50,042.66 -1,454.54
(-2.82%)

Nikkei 225

9,700.69 -0.68
(-0.01%)

Forex

USD-INR

88.75 0.20
(0.23%)

EUR-INR

102.26 0.13
(0.13%)

GBP-INR

116.57 0.18
(0.16%)

JPY-INR

0.58 0.00
(0.17%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Norris Medicines Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

524414

INE744C01029

-14.7915193

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

16.6

EPS(TTM)

Face Value()

Div & Yield %

Back

gail india ltd

GAIL (India) consolidated net profit declines 26.77% in the September 2025 quarter

Oct 31,2025

Net profit of GAIL (India) declined 26.77% to Rs 1972.40 crore in the quarter ended September 2025 as against Rs 2693.55 crore during the previous quarter ended September 2024. Sales rose 4.86% to Rs 35537.12 crore in the quarter ended September 2025 as against Rs 33888.90 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	35537.12	33888.90	5
OPM %	9.74	11.62	-
PBDT	3742.25	4391.63	-15
PBT	2565.39	3469.65	-26
NP	1972.40	2693.55	-27

25,597.65 -165.70 (-0.64%)

83,459.15 -519.34 ( -0.62%)

57,827.05 -274.40 ( -0.47%)

35,274.55 -378.50 ( -1.06%)

47,102.64 -255.05 (-0.54%)

6,792.56 -80.41 (-1.17%)

50,042.66 -1,454.54 (-2.82%)

9,700.69 -0.68 (-0.01%)

88.75 0.20 (0.23%)

102.26 0.13 (0.13%)

116.57 0.18 (0.16%)

0.58 0.00 (0.17%)